AC Immune presents at Jefferies Global Healthcare Conference
ACIU•AC Immune will attend the Jefferies Global Healthcare Conference in London on Nov. 16-19, 2026, where interim CEO Martin Zügel will present and join a fireside chat on Nov. 18.
ACIU•AC Immune will attend the Jefferies Global Healthcare Conference in London on Nov. 16-19, 2026, where interim CEO Martin Zügel will present and join a fireside chat on Nov. 18.
Interim CEO Martin Zügel will present and participate in a fireside chat on Nov. 18 at 11:30 GMT. Discussion will cover ACI-7104, an immunotherapy in Phase 2 development for early-stage Parkinson’s disease, and updates on AC Immune’s wholly owned portfolio.